Cargando…
Pazopanib-Induced Asymptomatic Necrotizing Pancreatitis Diagnosed on (18)F-FDG PET-CT Scan
Multi-targeted tyrosine kinase inhibitor (TKI) pazopanib approved for the treatment of advanced soft tissue sarcoma (STS) has prolonged the estimated survival times and quality of life of patients. However, several adverse effects associated predominantly with the inhibition of the vascular endothel...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771063/ https://www.ncbi.nlm.nih.gov/pubmed/35125763 http://dx.doi.org/10.4103/ijnm.ijnm_49_21 |